Arkolith/Insider Trading/AARD/Form 4

Chi Jeffrey

DirectorAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Feb 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Conversion(C)133K——133K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2025Conversion(C)1.1M—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-023311) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML